Alpine Immune Sciences (ALPN) Tops Q1 EPS by 3c

Alpine Immune Sciences (NASDAQ: ALPN) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $11.2 million.

For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79